{"entity":{"type":"insider","cik":"0001722024","url":"/insider/0001722024","json_url":"/insider/0001722024.json","name":"Alexandria Venture Investments, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2018-07-23","last":"2024-06-06","span_basis":"filed_date"},"name_variants":[{"name":"Alexandria Venture Investments, LLC","source":"filing","n_filings":11,"first_seen":"2018-07-23","last_seen":"2024-06-06"}],"transactions":[{"id":2775047,"accession":"0001035443-24-000171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001035443-24-000171","line_url":"/filing/0001035443-24-000171#line-2","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC","owner_display_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":636000.0,"total_display":"636,000.00","total_whole":"636,000","shares_owned_after":5855077.0,"shares_owned_after_display":"5,855,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-06","scope":"insider"},{"id":2775040,"accession":"0001035443-24-000171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001035443-24-000171","line_url":"/filing/0001035443-24-000171#line-1","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC","owner_display_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":631500.0,"total_display":"631,500.00","total_whole":"631,500","shares_owned_after":6005077.0,"shares_owned_after_display":"6,005,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":8065871,"accession":"0001035443-23-000315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001035443-23-000315","line_url":"/filing/0001035443-23-000315#line-2","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC","owner_display_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143450.0,"shares_display":"143,450","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":331369.5,"total_display":"331,369.50","total_whole":"331,370","shares_owned_after":5580077.0,"shares_owned_after_display":"5,580,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-06","scope":"insider"},{"id":8065862,"accession":"0001035443-23-000315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001035443-23-000315","line_url":"/filing/0001035443-23-000315#line-1","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC","owner_display_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103808.0,"shares_display":"103,808","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":240834.56,"total_display":"240,834.56","total_whole":"240,835","shares_owned_after":5723527.0,"shares_owned_after_display":"5,723,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-06","scope":"insider"},{"id":8193393,"accession":"0001035443-23-000308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001035443-23-000308","line_url":"/filing/0001035443-23-000308#line-2","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC; ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_display_name":"Alexandria Equities No. 7, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172742.0,"shares_display":"172,742","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":407671.12,"total_display":"407,671.12","total_whole":"407,671","shares_owned_after":5827335.0,"shares_owned_after_display":"5,827,335","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-02","scope":"insider"},{"id":8193388,"accession":"0001035443-23-000308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001035443-23-000308","line_url":"/filing/0001035443-23-000308#line-1","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC; ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_display_name":"Alexandria Equities No. 7, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155000.0,"shares_display":"155,000","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":373550.0,"total_display":"373,550.00","total_whole":"373,550","shares_owned_after":6000077.0,"shares_owned_after_display":"6,000,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-11-02","scope":"insider"},{"id":6646817,"accession":"0001035443-22-000176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001035443-22-000176","line_url":"/filing/0001035443-22-000176","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC; ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_display_name":"Alexandria Equities No. 7, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500000.0,"shares_display":"3,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","total_whole":"3,500,000","shares_owned_after":4555077.0,"shares_owned_after_display":"4,555,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider","n_lines":2},{"id":4408671,"accession":"0001035443-21-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001035443-21-000049","line_url":"/filing/0001035443-21-000049#line-3","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"Alexandria Venture Investments, LLC; Alexandria Equities No. 7, LLC; ALEXANDRIA REAL ESTATE EQUITIES, INC.","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43478.0,"shares_display":"43,478","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":999994.0,"total_display":"999,994.00","total_whole":"999,994","shares_owned_after":1287455.0,"shares_owned_after_display":"1,287,455","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":2352354,"accession":"0001722024-20-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001722024-20-000016","line_url":"/filing/0001722024-20-000016#line-2","is_derivative":false,"issuer_cik":"0001634379","issuer_name":"Metacrine, Inc.","issuer_ticker":"MTCR","issuer_name_source":null,"issuer_url":"/issuer/0001634379","owner_cik":"0001722024","owner_name":"Alexandria Venture Investments, LLC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":"/insider/0001722024","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38461.0,"shares_display":"38,461","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":499993.0,"total_display":"499,993.00","total_whole":"499,993","shares_owned_after":1307256.0,"shares_owned_after_display":"1,307,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-18","scope":"insider"},{"id":8745481,"accession":"0001722024-19-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001722024-19-000017","line_url":"/filing/0001722024-19-000017#line-2","is_derivative":false,"issuer_cik":"0001722024","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001722024","owner_cik":"0001722024","owner_name":"Alexandria Venture Investments, LLC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":"/insider/0001722024","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":480000.0,"total_display":"480,000.00","total_whole":"480,000","shares_owned_after":244447.0,"shares_owned_after_display":"244,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-05","scope":"insider"},{"id":8658169,"accession":"0001722024-19-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001722024-19-000012","line_url":"/filing/0001722024-19-000012#line-2","is_derivative":false,"issuer_cik":"0001676725","issuer_name":"IDEAYA Biosciences, Inc.","issuer_ticker":"IDYA","issuer_name_source":null,"issuer_url":"/issuer/0001676725","owner_cik":"0001722024","owner_name":"Alexandria Venture Investments, LLC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":"/insider/0001722024","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":432384.0,"shares_owned_after_display":"432,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":8025839,"accession":"0001035443-19-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001035443-19-000142","line_url":"/filing/0001035443-19-000142#line-2","is_derivative":false,"issuer_cik":"0001035443","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001035443","owner_cik":null,"owner_name":"Alexandria Venture Investments, LLC; Alexandria Equities No. 7, LLC; ALEXANDRIA REAL ESTATE EQUITIES INC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":975000.0,"shares_display":"975,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":9750000.0,"total_display":"9,750,000.00","total_whole":"9,750,000","shares_owned_after":975000.0,"shares_owned_after_display":"975,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-20","scope":"insider"},{"id":6247934,"accession":"0001722024-18-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001722024-18-000014","line_url":"/filing/0001722024-18-000014#line-2","is_derivative":false,"issuer_cik":"0001330436","issuer_name":"Liquidia Technologies Inc","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001330436","owner_cik":"0001722024","owner_name":"Alexandria Venture Investments, LLC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":"/insider/0001722024","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":136364.0,"shares_display":"136,364","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1500004.0,"total_display":"1,500,004.00","total_whole":"1,500,004","shares_owned_after":396172.0,"shares_owned_after_display":"396,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-08-01","scope":"insider"},{"id":6303642,"accession":"0001722024-18-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001722024-18-000010","line_url":"/filing/0001722024-18-000010#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001722024","owner_name":"Alexandria Venture Investments, LLC","owner_display_name":"Alexandria Venture Investments, LLC","owner_url":"/insider/0001722024","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66667.0,"shares_display":"66,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1000005.0,"total_display":"1,000,005.00","total_whole":"1,000,005","shares_owned_after":216304.0,"shares_owned_after_display":"216,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001697532","name":"Applied Therapeutics, Inc.","url":"/issuer/0001697532","role":"Ten percent owner","n_filings":6,"first_seen":"2019-05-20","last_seen":"2024-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001634379","name":"Metacrine, Inc.","url":"/issuer/0001634379","role":"Ten percent owner","n_filings":1,"first_seen":"2020-09-18","last_seen":"2020-09-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001771917","name":"Karuna Therapeutics, Inc.","url":"/issuer/0001771917","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-05","last_seen":"2019-07-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001676725","name":"IDEAYA Biosciences, Inc.","url":"/issuer/0001676725","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-30","last_seen":"2019-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001330436","name":"Liquidia Technologies Inc","url":"/issuer/0001330436","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-01","last_seen":"2018-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001722024","retrieved_at":"2026-08-24T19:55:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}